This inventor holds 9 USPTO granted patents, plus 2 CIPO patents. Top assignee: Genentech, Inc.. Active years: 1990-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1998
Title: Adair J Hotchkiss: Innovator in Human Tissue Plasminogen Activator Variants
Introduction
Adair J Hotchkiss is a prominent inventor based in Half Moon Bay, California. He has made significant contributions to the field of biotechnology, particularly in the development of human tissue plasminogen activator variants. With a total of nine patents to his name, Hotchkiss has established himself as a key figure in medical innovation.
Latest Patents
Hotchkiss's latest patents include novel variants of tissue plasminogen activator (t-PA) that exhibit surprising biological and pharmacokinetic properties compared to the native t-PA. These variants demonstrate increased half-life profiles and maintain good fibrin binding activity, even with deletions in the fibrin binding regions of the molecule. Additionally, he has developed a human tissue-type plasminogen activator variant that retains substantially full biological activity while featuring a modified carbohydrate structure and an altered in vivo half-life. The patents also disclose methods for preparing these variants recombinantly and their functional assays.
Career Highlights
Hotchkiss is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work has significantly advanced the understanding and application of tissue plasminogen activators in medical treatments.
Collaborations
Some of his notable coworkers include Deborah L Higgins and Stephen P Anderson, who have collaborated with him on various projects related to his patents and innovations.
Conclusion
Adair J Hotchkiss continues to be a driving force in the field of biotechnology, particularly through his innovative work on human tissue plasminogen activator variants. His contributions are paving the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
